Securities code: Boya Bio-Pharmaceutical Group Co.Ltd(300294) securities abbreviation: Boya Bio-Pharmaceutical Group Co.Ltd(300294) Announcement No.: 2022011 Boya Bio-Pharmaceutical Group Co.Ltd(300294)
Indicative announcement of annual report disclosure in 2021
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Special note: the full text of the 2021 annual report and the summary of the 2021 annual report of the company have been disclosed on the gem information disclosure website designated by the CSRC on March 23, 2022. Please pay attention to the information!
On March 22, 2022, Boya Bio-Pharmaceutical Group Co.Ltd(300294) (hereinafter referred to as “the company”) held the 15th meeting of the 7th board of directors and the 12th meeting of the 7th board of supervisors, deliberated and adopted the proposal on the full text and summary of the company’s annual report in 2021, so as to enable investors to fully understand the company’s operating results, financial situation and future development plan, The full text of the company’s 2021 annual report and the summary of the 2021 annual report were posted on the gem information disclosure website cninfo.com (website: http://www.cn.info.com.cn. ）Disclosure on.
Please pay attention to the investors.
It is hereby announced.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) board of directors March 22, 2022
